Home > Income Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Revenue

    Back to Income Statement
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹235 Cr₹198 Cr₹154 Cr₹140 Cr₹114 Cr

What is the latest Revenue of KILITCH DRUGS (INDIA) ?

The latest Revenue ratio of KILITCH DRUGS (INDIA) is ₹235 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹235 Cr
Mar2025₹198 Cr
Mar2024₹154 Cr
Mar2023₹140 Cr
Mar2022₹114 Cr

How is Revenue of KILITCH DRUGS (INDIA) Trending?

Years Revenue % Change
Mar2026 ₹235 Cr
18.74
Mar2025 ₹198 Cr
28.47
Mar2024 ₹154 Cr
10.58
Mar2023 ₹140 Cr
22.20
Mar2022 ₹114 Cr -

Compare Revenue of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹728.7 Cr 2.2% -4.2% 6.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.9% -5% 3.2% Stock Analytics
DIVIS LABORATORIES ₹251,611.0 Cr 3.6% -1.4% 37.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,182.0 Cr 1.7% -6.7% 28% Stock Analytics
CIPLA ₹109,063.0 Cr 2.8% -3.9% -17.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,926.0 Cr 5.4% 8.7% 1.6% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

2.2%

-4.2%

6.8%

SENSEX

-0.3%

-1.6%

-12.3%


You may also like the below Video Courses